A Phase 3, 56-Week, Randomised, Double-Blind, Placebo-Controlled Study (OA-11) Utilising Patient-Reported and Radiographic Outcomes Evaluating the Efficacy and Safety of a Lorecivivint Injection in Patients with Moderate to Severe Knee Osteoarthritis.
Clinical and experimental rheumatology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined